May 2nd 2024
In a new real-world study, Sanofi and AstraZeneca’s nirsevimab-alip (Beyfortus) demonstrated high efficacy against respiratory syncytial virus (RSV) lower respiratory tract disease (LRTD).
Surv.AI Says: Real-World Insights into the Journey for Patients with Pulmonary Arterial Hypertension
May 21, 2024
Register Now!
Medical Crossfire®: How Can Thoracic Teams Facilitate Optimized Care of Patients With Stage I-III EGFR Mutation-Positive NSCLC?
May 21, 2024
Register Now!
Medical Crossfire®: Maximizing Patient Outcomes in Shingles – Are You Leveraging Guideline Based Care?
View More
Understanding RSV: What You Need to Know to Prevent and Treat Respiratory Syncytial Virus in Your Patients
View More
Respiratory Syncytial Virus: Understanding the Infection Burden and Anticipating the Impact of Vaccines
View More
(COPE Credit) Community Practice Connections™: Keeping an Eye on Evolving Management Strategies for nAMD and DME
View More
(CME Credit) Community Practice Connections™: Keeping an Eye on Evolving Management Strategies for nAMD and DME
View More
Medical Crossfire®: Which Patients with Hematologic Malignancies are at Risk for Secondary Immunodeficiency (SID)… and How Can We Leverage Evidence to Improve Their Outcomes?
View More
Addressing Healthcare Inequities™ in Glaucoma Management – Understanding Challenges in Segmented Patient Populations (CME Track)
View More
Community Practice Connections™: Real-World Applications of Novel Therapies Across TNBC and Addressing Disparities in Care
View More
Tackling Inequities in IBD: Inclusive Solutions for Elevated Patient Care
October 26, 2024
Register Now!
Advances in TNBC: Communicating with Your Patients About Clinical Trial Awareness and Treatment Concerns to Improve Clinical Outcomes
View More
6th Annual Advanced Practice Collaborative
View More
Community Practice Connections™: 24th Annual International Lung Cancer Congress®
View More
19th Annual New York Lung Cancers Symposium®
November 16, 2024
Register Now!
Patient, Provider, and Caregiver Connection™: Prevention and Control of Meningococcal Disease — Individualizing Vaccine Recommendations in Adolescent Populations
View More
Shaping the Management of COPD with Biologic Therapy
View More
Let’s Get “Real”: Alpha-1 Antitrypsin Deficiency—Case-Based Perspectives on Managing Associated Emphysema
View More
Elevating Care for PAH: Applying Recommended Management Approaches to Maximize Outcomes
View More
Community Practice Connections™: 5th Annual Precision Medicine Symposium – An Illustrated Tumor Board
View More
EGPA: Highlighting the Patient Journey to Improve the Differential Diagnosis and Accelerate the Initiation of Guideline-Based Care
View More
Identifying Actionable Biomarkers in NSCLC: Real World Case Discussions on Applications of Testing in the Treatment Planning Process
View More
Community Oncology Connections™: Overcoming Barriers to Testing, Trial Access, and Equitable Care in Cancer
View More
Improving Outcomes Across Frontline and R/R SCLC Care in Community Treatment Settings
View More
Addressing Healthcare Inequities: Bridging the Gap in Multiple Sclerosis – A Focus on Clinical and Healthcare Disparities in Black Patients
View More
Overcoming Racial Disparities in Multiple Myeloma Outcomes and Clinical Trials: How We are Moving Care Forward Today
View More
Clinical ShowCase™: Finding the Best Path Forward for Patients with COPD
View More
Community Practice Connections™: The 2nd Annual Hawaii Lung Cancers Conference®
View More
Charting the Path to Precision Diagnosis: Detection and Treatment Approaches for Oncogenic Mutations in NSCLC
View More
The Role of Vaccines in the Fight Against Antibiotic Resistance
October 9th 2016Following the recent United Nations General Assembly meeting to discuss the growing global threat of antimicrobial resistance, health experts are highlighting the role vaccines can play in preventing dangerous infections.
Read More
Healthcare Provider Attitudes Toward Seasonal Influenza Vaccine Policies
October 8th 2016To assess factors associated with the likelihood that healthcare providers will accept seasonal influenza vaccine policy changes, Nova Scotia researchers examined the roles that their knowledge and attitude play in the matter.
Read More
A New Meaning to "Getting Tested"
October 6th 2016Over-the-counter diagnostic tests for Chlamydia trachomatis, Neisseria gonorrhoeae, and pathogens associated with upper respiratory tract infections such as influenza and Group A Streptococcus may soon gain approval; however, making these tests immediately available to the public would not be without challenges.
Read More
CDC Director Recommends Receiving Flu Shot Before End of October
September 30th 2016At this year’s annual National Foundation for Infectious Diseases news conference on influenza and pneumococcal disease, the message was clear as health experts issued a resounding call for all Americans 6 months of age and older to get their flu shot.
Read More
New CDC Report Gives Insight Into Effectiveness of This Season's Flu Vaccine
September 27th 2016A recent report from the Centers for Disease Control and Prevention (CDC) shows influenza viruses currently in circulation in the United States are the same as anticipated by vaccine makers, hopefully signaling effectiveness ahead for 2016-2017 Northern Hemisphere influenza vaccines.
Read More
Progesterone May Protect Women Against Dangerous Effects of Influenza
September 23rd 2016The World Health Organization credits contraception with preventing pregnancy-related health risks in women, reducing adolescent pregnancies, and lowering infant mortality rates. What researchers are now discovering is that hormonal contraceptives containing progesterone may also protect women against influenza infections and repair lung damage caused by inflammation.
Read More
Walgreens & HHS Provide Uninsured Americans with $10 Million Worth of Free Flu Shot Vouchers
September 15th 2016Walgreens has partnered up again with the US Department of Health in an effort to improve rates of flu vaccination by providing over $10 million in free flu shot vouchers for Americans who are uninsured.
Read More
Social Connectivity Can Impact Dynamics of Disease Transmission
September 12th 2016A new study has shown that infected wild house mice will disengage from their social groups, resulting in a decreased potential for disease transmission; these findings can be applied to improve models used to predict transmission of infectious diseases spread by social contact, such as Ebola and influenza.
Read More
New Study Explains Link Between Influenza and Deadly MRSA Infection
August 17th 2016According to the new study, the antibacterial response of white blood cells to the flu virus fails to target the S. aureus bacteria and instead causes inflammatory injury to the lungs and damage to surrounding tissue, creating a higher susceptibility to secondary bacterial infections such as MRSA pneumonia.
Read More
Shorter Antibiotic Regimens Recommended for Treatment of Pneumonia
August 1st 2016The IDSA and ATS have updated the Clinical Practice Guidelines for HAP & VAP for the first time since 2005 to recommend that each hospital generate antibiograms and reduce the use of antibiotics in treatment regiments.
Read More